Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy

Por Beloueche-Babari, M, Chung, Y-L, Al-Saffar, N M S, Falck-Miniotis, M, Leach, M O
Publicado em 2010

The HIF-pathway inhibitor NSC-134754 induces metabolic changes and anti-tumour activity while maintaining vascular function

Por Baker, L C J, Boult, J K R, Walker-Samuel, S, Chung, Y-L, Jamin, Y, Ashcroft, M, Robinson, S P
Publicado em 2012

Dichloroacetate induces autophagy in colorectal cancer cells and tumours

Por Lin, G, Hill, D K, Andrejeva, G, Boult, J K R, Troy, H, Fong, A-C L F W T, Orton, M R, Panek, R, Parkes, H G, Jafar, M, Koh, D-M, Robinson, S P, Judson, I R, Griffiths, J R, Leach, M O, Eykyn, T R, Chung, Y-L
Publicado em 2014